ADIA — Adia Med, Inc.
—
OTC ·
Materials ·
Chemicals ·
CIK 1160420 ·
Last close
$0.12
Market Cap
$11.71M
52W High
$0.28
52W Low
$0.02
ADV30
26,050
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 485,385 | 282,580 | 51,829 | 40,418 | 744,054 | 128,115 | 1,123,835 |
| Mar 2026 | 176,275 | 67,577 | -151,920 | -162,525 | 776,868 | 136,716 | 1,197,067 |
| Dec 2025 | 63,363 | -51,790 | -212,439 | -219,358 | 594,826 | 79,392 | 852,500 |
| Sep 2025 | 364,391 | 211,185 | 84,396 | 75,572 | 776,215 | 153,870 | 846,781 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-175,765
Investing CF
$-26,043
Financing CF
$214,824
CapEx
$-22,298
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-16,095,589
Inventory
$140,500
Receivables
$44,635
ST Investments
$6,450
EBIT TTM
$-224,616
Pretax Income TTM
$-265,893
Interest Exp TTM
$41,277
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,172,258
EBITDA
$-207,044
Free Cash Flow
—
Enterprise Value
$13,292,630
Total Cash
$128,115
Total Debt
$993,777
Shares Out
94,404,696
Trailing EPS
$0.00
Book Value
$-0.01
ROE
—
ROA
—
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 700,508 | -366,492 | -395,464 | 594,826 | 852,500 | -257,674 | -179,228 |
| Dec 2024 | 6,380 | -174,749 | -181,067 | 666,181 | 640,641 | 25,540 | -335,476 |
| Dec 2023 | 0 | 0 | 0 | 500 | 1,250 | -750 | 0 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$744,054
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BIOX | Bioceres Crop Solutions Corp. | $12.13M | $0.19 | — |
| LOOP | Loop Industries, Inc. | $10.36M | $0.21 | — |
| FRTT | Fort Technology Inc | $10.16M | $0.68 | — |
| KARX | Karbon-X Corp. | $13.89M | $0.13 | — |
| BNET | BION ENVIRONMENTAL TECHNOLOGIES INC | $9.30M | $0.16 | — |
News headlines (Yahoo Finance, 1h cache)
ADIA Med Nearly Doubles Nine-Month Revenue to Surpass $1 Million
2026-11-17 13:00 · Yahoo
Adia Med CEO Larry Powalisz Issues Open Letter on Leadership Journey, Research Mission, and Progress Since 2024
2026-11-09 13:00 · Yahoo
Adia Med Reports No Serious Adverse Events in First Cohort of Pediatric Autism Study; Enrollment Continues
2026-10-26 12:00 · Yahoo
Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz for $350,000 in Cash
2026-10-20 12:00 · Yahoo
Adia Med Fully Repays Related-Party Credit Facility, Strengthening Its Financial Position
2026-10-13 13:00 · Yahoo
Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million
2026-10-06 13:20 · Yahoo
Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line
2026-09-29 12:00 · Yahoo
Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological Products
2026-09-22 12:00 · Yahoo
Adia Med Submits Fifth 2026 Clinical Study to IRB: Osteoarthritis Protocol for One-Time Systemic Treatment
2026-09-15 12:00 · Yahoo
Nasdaq Shareholder Requirements Just Verified By Adia Med
2026-09-08 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.